Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada flag Canada · Delayed Price · Currency is CAD
0.1650
+0.0100 (6.45%)
Aug 10, 2026, 3:45 PM EST

Voyageur Pharmaceuticals Financials Overview

Millions CAD. Fiscal year is Dec - Nov.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Revenue
0.050.01----
Revenue Growth
------
Gross Profit
00----
Operating Income
-3.91-3.53-1.71-1.4-1.76-2.05
Net Income
-3.8-3.53-1.71-1.4-1.75-2.05
Earnings Per Share
-0.02-0.02-0.01-0.01-0.02-0.02
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Investments
0.440.270.1700.030.81
Total Debt
0.040.040.040.040.030.04
Net Cash (Debt)
0.40.230.13-0.040.010.77
Net Cash Growth
18.76%80.82%---99.22%-
Net Cash Per Share
0.000.000.00-0.000.000.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Cash Flow
-1.01-2.89-0.3-0.99-1.72-1.65
Capital Expenditures
-----0-0.02
Free Cash Flow
-1.01-2.89-0.3-0.99-1.72-1.67
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Gross Margin
0.00%0.00%----
Operating Margin
-8269.30%-30231.60%----
Pretax Margin
-8269.30%-30231.56%----
Profit Margin
-8033.93%-30231.60%----
FCF Margin
-2144.78%-24756.50%----

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
742.672445.35----